Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0416666666666667 0.00625000000000012 1.15648231731787E-16 -0.00187499999999991
Stock impact report

Streetwise Reports Interviews Executives at Biotech Company with Transformative RNAi Delivery System

RXI PHARMACEUTICALS CORP (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com
Company Research Source: Marketwire
SAN FRANCISCO, CA -- (Marketwired) -- 10/05/17 -- With data from multiple studies due out this quarter, this biotech's RNA interference delivery platform has the potential to transform treatments for indications from cancer to ophthalmology, says Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals, Dr. Gerrit Dispersyn, RXi's Chief Development Officer, and Dr. Karen Bulock, Vice President of Research at RXi. Included in this interview is: RXi Pharmaceuticals Corp. (NASDAQ: RXII) The Life Sciences Report: How far has RXi Pharmaceuticals Corp. come in the last 10 years? Geert Cauwenbergh: Since the codiscovery of RNAi by Dr. Craig Mello, the field has had to overcome many development hurdles. In the beginning, the main issue was efficient delivery of RNAi compounds to tissues and cells. RXi took the time to examine the delivery aspect and developed a technology platform where delivery and therapeutic properties are built direc Show less Read more
Impact Snapshot
Event Time:
RXII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RXII alerts
Opt-in for
RXII alerts

from News Quantified
Opt-in for
RXII alerts

from News Quantified